Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles
نویسندگان
چکیده
منابع مشابه
Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles.
Neurodegeneration is characterized by progressive loss of structure and function of neurons. Several therapeutic methods and drugs are available to alleviate the symptoms of these diseases. The currently used delivery strategies such as implantation of catheters, intracarotid infusions, surgeries, and chemotherapies are invasive in nature and pose a greater risk of postsurgical complications, w...
متن کاملIntranasal Delivery of Chitosan Nanoparticles for Migraine Therapy
OBJECTIVE The objective of the research was to formulate and evaluate sumatriptan succinate-loaded chitosan nanoparticles for migraine therapy in order to improve its therapeutic effect and reduce dosing frequency. MATERIAL AND METHODS The Taguchi method design of experiments (L9 orthogonal array) was applied to obtain the optimized formulation. The sumatriptan succinate-loaded chitosan nanop...
متن کاملEnzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
A key goal of our recent research efforts has been to develop novel 'triggerable nanoparticle' systems with real potential utility in vivo. These are designed to be stable from the point of administration until a target site of interest is reached, then triggered for the controlled release of therapeutic agent payload(s) at the target site by changes in local endogenous conditions or through th...
متن کاملIntranasal delivery of cells to the brain.
The safety and efficacy of cell-based therapies for neurodegenerative diseases depends on the mode of cell administration. We hypothesized that intranasally administered cells could bypass the blood-brain barrier by migrating from the nasal mucosa through the cribriform plate along the olfactory neural pathway into the brain and cerebrospinal fluid (CSF). This would minimize or eliminate the di...
متن کاملErratum to “Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy” [Sci Pharm. 2013; 81: 843–854]
This is an erratum to the article 'Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy' [Sci Pharm. 2013; 81: 843–854]. Figures 1–3 are added.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pharmaceutics
سال: 2013
ISSN: 2090-9918,2090-7818
DOI: 10.1155/2013/812387